Get details at ajnabiosciences.com- Early-bird bonus shares will expire soon. Ajna is advancing some of the first FDA-regulated natural pharmaceuticals—including a psilocybin drug for anxiety and a full-spectrum cannabinoid drug entering

Phase 2 trials for Autism.

If you're excited by a future where evidence-based plant medicines are available at the pharmacy, prescribed by physicians, and covered by insurance for millions in need—this is your opportunity to help shape that future.

Visit ajnabiosciences.com for more on our mission, pipeline, and how to invest.